Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study - Takeaways - MDSpire

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study

  • By

  • Ozlem Candan

  • Narmin Naghizada

  • Tekin Tuncel

  • Beyza Melek Palaz

  • Mustafa Alperen Tunc

  • Derya Demirtas

  • Ahmet Mert Yanik

  • Arda Bayar

  • Secil Salim

  • Fatma Temiz

  • Ceren Uzunoglu Guren

  • Fatma Arıkan

  • Meral Ulukoylu Menguc

  • Asu Fergun Yilmaz

  • Isik Atagunduz

  • Zekaver Odabası

  • Tayfur Toptas

  • Ayse Tulin Tuglular

  • May 14, 2026

  • 0 min

Share

  • 1

    Infections occurred in 50.9% of newly diagnosed multiple myeloma patients, peaking during the first three months of induction therapy.

  • 2

    Pneumonia was the most common infection, with gram-negative bacteria like Escherichia coli being the most prevalent pathogens identified.

  • 3

    Advanced ISS stage, diabetes mellitus, and chronic kidney disease were identified as independent risk factors for infections in multiple myeloma patients.

  • 4

    Lymphocyte levels significantly decreased during febrile episodes, suggesting a potential link to immune function in infection susceptibility.

  • 5

    The study emphasizes the need for risk-adjusted infection prevention strategies based on clinical indicators during the early treatment phase.

Original Source(s)

Related Content